Mansbach RS[au] - Search Results

Year	Number of Results
1983	1
1984	2
1986	3
1987	2
1988	4
1989	3
1990	6
1991	6
1992	2
1993	2
1994	2
1995	2
1996	3
1997	2
1998	2
1999	1
2000	1
2001	1
2003	1
2005	2
2006	3
2007	2
2010	1
2011	1
2018	1
2021	1
2023	0

1

Startle response models of sensorimotor gating and habituation deficits in schizophrenia.

Geyer MA, Swerdlow NR, Mansbach RS, Braff DL. Geyer MA, et al. Among authors: mansbach rs. Brain Res Bull. 1990 Sep;25(3):485-98. doi: 10.1016/0361-9230(90)90241-q. Brain Res Bull. 1990. PMID: 2292046 Review.

2

Incorporating the assessment of abuse liability into the drug discovery and development process.

Mansbach RS, Feltner DE, Gold LH, Schnoll SH. Mansbach RS, et al. Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S73-85. doi: 10.1016/s0376-8716(03)00100-5. Drug Alcohol Depend. 2003. PMID: 12759198 Review.

3

Cholecystokinin (CCK-8) elicits prandial sleep in rats.

Mansbach RS, Lorenz DN. Mansbach RS, et al. Physiol Behav. 1983 Feb;30(2):179-83. doi: 10.1016/0031-9384(83)90002-1. Physiol Behav. 1983. PMID: 6302718

4

Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits.

Petraitiene R, Petraitis V, Maung BBW, Mansbach RS, Hodges MR, Finkelman MA, Shaw KJ, Walsh TJ. Petraitiene R, et al. Among authors: mansbach rs. Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01795-20. doi: 10.1128/AAC.01795-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33361304 Free PMC article.

5

Formulation considerations for the development of medications with abuse potential.

Mansbach RS, Moore RA Jr. Mansbach RS, et al. Drug Alcohol Depend. 2006 Jun;83 Suppl 1:S15-22. doi: 10.1016/j.drugalcdep.2005.10.018. Epub 2006 Feb 10. Drug Alcohol Depend. 2006. PMID: 16472940

6

Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis.

Zhao Y, Lee MH, Paderu P, Lee A, Jimenez-Ortigosa C, Park S, Mansbach RS, Shaw KJ, Perlin DS. Zhao Y, et al. Among authors: mansbach rs. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00425-18. doi: 10.1128/AAC.00425-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30012766 Free PMC article.

7

Dopaminergic stimulation disrupts sensorimotor gating in the rat.

Mansbach RS, Geyer MA, Braff DL. Mansbach RS, et al. Psychopharmacology (Berl). 1988;94(4):507-14. doi: 10.1007/BF00212846. Psychopharmacology (Berl). 1988. PMID: 3131796

8

Effects of mazindol on behavior maintained or occasioned by cocaine.

Mansbach RS, Balster RL. Mansbach RS, et al. Drug Alcohol Depend. 1993 Jan;31(2):183-91. doi: 10.1016/0376-8716(93)90071-w. Drug Alcohol Depend. 1993. PMID: 8436063

9

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD 3rd, O'Neill BT. Coe JW, et al. Among authors: mansbach rs. J Med Chem. 2005 May 19;48(10):3474-7. doi: 10.1021/jm050069n. J Med Chem. 2005. PMID: 15887955

10

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

Mansbach RS, Geyer MA. Mansbach RS, et al. Neuropsychopharmacology. 1989 Dec;2(4):299-308. doi: 10.1016/0893-133x(89)90035-3. Neuropsychopharmacology. 1989. PMID: 2692589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year